Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Recovery of Heart Rate Variability in Handball Players (HRV-HANDBAll)

30 de agosto de 2026 actualizado por: Ramiz ARABACI, Uludag University

Effects of Manual Massage and Foam Rolling on Heart Rate Variability Following 20m-Shuttle Run Test in Elite Male Handball Players

This study aimed to compare the acute effects of manual massage (MM) and foam rolling (FR) on heart rate variability (HRV) following a 20 m shuttle run test (20m-SRT) in elite male handball players. It was hypothesized that MM and FR would produce differential acute effects on HRV responses during

Descripción general del estudio

Descripción detallada

The aim of present study was to compare the acute effects of manual massage (MM) and foam rolling (FR) on time-domain and frequency-domain HRV parameters following a 20 m shuttle run test (20m-SRT) in elite male handball players. It was hypothesized that MM and FR would produce differential acute effects on HRV responses during. Fifteen elite male handball players voluntarilly participated in present study.

The research utilized a randomized cross-over design. All participants provided written informed consent after being briefed about the aims, procedures, benefits, and risks. Study was conducted in three sessions in onwe week. Fırst session is familiarization, other two sessions are experimental: MM and FR sessions. Participants were instructed to maintain their normal diet, refrain from intense exercise for at least 48 hours before study sessions, avoid alcohol and caffeine intake for 24 hours prior, and consume their last meal at least 3 hours before sessions. In familiarization session, subjects fulfilled Exercise Readiness Questionnaire (EGZ+), measured body composition, after warm-up 20m-SRT, and recovery interventions (MM and FR). Before warm-up - pre-test, during 20-m shuttle run test - test and after recovery - post-test HRV were recorded. In experimental session, after the 20 min standard warm-up including jogging, jumping and stretching volunteers performed 20m-SRT and immediately one of two different recovery interventions. Recovery interventions are MM and FR applied on the lower extremities. All procedures were conducted at the same time of day (14:00-16:00) to minimize circadian rhythm effects. To determine differences in HRV and heart rate across recovery methods and time points, a Two Way Repeated Measures ANOVA was used: 2 Intervention (MM and FR) × 3 Time (Pre-test, Test, Post-test). Bonferroni-adjusted pairwise comparisons performed to identify differences between specific time points and interventions.

Tipo de estudio

Intervencionista

Inscripción (Actual)

15

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

      • Bursa, Turquía (Türkiye), 16059
        • Bursa uludag University, Faculty of Sport Sciences

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Niño
  • Adulto

Acepta Voluntarios Saludables

Sí

Descripción

Inclusion Criteria:

  • Male handball players competing in the Turkish Handball Super League
  • At least 5 years of regular handball training experience
  • Participation in at least 10 official matches during the previous 12 months
  • Minimum 1 year of playing experience in the Turkish Handball Super League
  • No injury resulting in an interruption of training or competition for more than 2 weeks during the previous 6 months
  • No use of stimulants, ergogenic aids, or prohibited performance-enhancing substances

Exclusion Criteria:

  • Current musculoskeletal injury or pain affecting training or match participation
  • History of surgery to the lower or upper extremities within the previous 12 months
  • Presence of cardiovascular, neurological, or metabolic disorders
  • Use of medications that may affect physical performance or neuromuscular function
  • Inability to complete the study procedures or testing protocol
  • Withdrawal of informed consent

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Otro
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación cruzada
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Manual Massage (MM)
After the 20 minute standard warm-up including jogging, jumping and stretching participant performed 20 m Shuttle Run Test (20m-SRT), subsequently legs Manual Massage (MM) recovery intervention lasted 20 minutes. Before warm-up, during 20m-SRT and MM HRV was recorded.
MM protocol employed Swedish massage techniques (Hemmings, 2001; Tessier, 2005), including effleurage (light stroking), friction, petrissage (kneading and rolling), vibration and tapotement (light percussion). Massage was applied for 20 minutes total, distributed as: 10 minutes on the right and 10 minutes on the left lower extremity. Posterior lower-extremity massage included the gluteal region, posterior thigh, and calf muscles. Anterior lower-extremity massage included only the quadriceps. Applications were performed from distal to proximal direction using baby oil by certified masseur. Anterior leg massage in a supine position and posterior leg massage in a prone position was applied
Experimental: Foam Rolling (FR)
After the 20 minute standard warm-up including jogging, jumping and stretching participant performed 20 m Shuttle Run Test (20m-SRT), subsequently legs Foam Rolling (FR) recovery intervention lasted 20 minutes. Before warm-up, during 20m-SRT and FR HRV was recorded.
A medium density, grid structured foam roller (Blackroll Standard, 33×15×14 cm, PVC polypropylene, Bottighofen, Switzerland) was used. Participants performed self-myofascial release by placing the lower extremities on the foam roller and rolling forward and backward to relax fascia surrounding the muscle with medium pressure. Total duration of FR lasted 20 minutes: 10 minutes left and 10 minutes right lower extremity. Rolling was performed at a controlled cadence (~30 cycles/min) guided by a metronome with moderate pressure.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Heart Rate Variability (HRV)
Periodo de tiempo: From enrollment to the end of treatment at 60 minutes
HRV was recorded by Polar V800 (Polar Electro, Kempele, Finland) heart rate monitor and chest strap of Polar H10 transmitter. HRV time-domain (RR, RMSSD, SDNN) and frequency-domain (VLF, LF, HF) markers and heart rate (HR) were recorded and transferred in Polar Flow. Data set normalized by adopting artefact methodology using Kubios HRV Scientific (Tarvainen et al., 2014). Power values were calculated in normalized units (n.u.). HRV recordings were obtained during three phases: pre exercise (10 min supine rest), during exercise and post exercise recovery phases (10 min supine rest. Participants were instructed to maintain spontaneous but stable breathing during recordings.
From enrollment to the end of treatment at 60 minutes
20 m Shuttle Run Test (VO2max)
Periodo de tiempo: After warm-up 20m-SRT lasted approximately 12-15 minute
20m-SRT was administered following the protocol of Leger and Lambert (1982). The running pace was controlled by "beep test" audio signals. The test started at a speed of 8.5 km·h-¹, increasing by 0.5 km·h-¹ every minute. Participants were required to cover 20 m at each signal. The test ended when a participant failed to complete the 20 m distance three consecutive times. Estimated VO2max values were calculated using the Leger et al. (1988) formula.
After warm-up 20m-SRT lasted approximately 12-15 minute

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Height
Periodo de tiempo: 1 minute during familiarisation session
Standing height was measured with a SECA 216 digital stadiometer with a precision of 0.01 m.
1 minute during familiarisation session
Weight
Periodo de tiempo: 1 minute during familiarisation session
Body weight (kg) were measured using a TANITA BC 418MA Segmental Body Composition Analyzer (±0.50 kg accuracy).
1 minute during familiarisation session
Total Body Fat
Periodo de tiempo: 1 minute during familiarisation session
Total body fat (%) were measured using a TANITA BC 418MA Segmental Body Composition Analyzer (±0.50 kg accuracy).
1 minute during familiarisation session
Body Mass Index
Periodo de tiempo: 1 minute during familiarisation session
Weight and height will be combined to report BMI in kg/m^2
1 minute during familiarisation session

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de mayo de 2025

Finalización primaria (Actual)

30 de junio de 2025

Finalización del estudio (Actual)

31 de julio de 2025

Fechas de registro del estudio

Enviado por primera vez

3 de junio de 2026

Primero enviado que cumplió con los criterios de control de calidad

9 de junio de 2026

Publicado por primera vez (Actual)

15 de junio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

2 de septiembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

30 de agosto de 2026

Última verificación

1 de agosto de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • 2023-20/71014

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Descripción del plan IPD

only IPD used in the results publication

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir